Who are Chemomab Therapeutics Ltd.'s main suppliers?

Chemomab Therapeutics Ltd. (CMMB) key suppliers include: Edesa Biotech, Inc., Mirum Pharmaceuticals, Inc.. View the full supplier network at chainsifter.com/chain/CMMB.

Who are Chemomab Therapeutics Ltd.'s major customers?

Chemomab Therapeutics Ltd. (CMMB) key customers include: Edesa Biotech, Inc., Mirum Pharmaceuticals, Inc., CHEMOMAB-THERAPEUTICS-INC. View the full customer network at chainsifter.com/chain/CMMB.

What sector is Chemomab Therapeutics Ltd. in?

Chemomab Therapeutics Ltd. (CMMB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Chemomab Therapeutics Ltd. (CMMB): 6 Verified Supply Chain Relationships

2Suppliers

3Customers

1Debt Items

18Related Chains

Source-Backed Evidence Depth

Chemomab Therapeutics Ltd. (CMMB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

2Distinct source URLs

1High confidence

0.733Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Chemomab Therapeutics Ltd. Suppliers

Ticker	Name	Confidence	Evidence
EDSA	Edesa Biotech, Inc.	72%	Reciprocal relationship from EDSA graph: Reciprocal relationship from CMMB graph: Reciprocal relationship from EDSA graph: ly reported that supplies of raw materials and critical components necessary…
MIRM	Mirum Pharmaceuticals, Inc.	72%	Reciprocal relationship from MIRM graph: Reciprocal relationship from CMMB graph: Reciprocal relationship from MIRM graph: with such services. Under certain circumstances, we may be required to repor…

Chemomab Therapeutics Ltd. Customers

Ticker	Name	Confidence	Evidence
EDSA	Edesa Biotech, Inc.	72%	Reciprocal relationship from EDSA graph: Reciprocal relationship from CMMB graph: Reciprocal relationship from EDSA graph: Reciprocal relationship from CMMB graph: Reciprocal relationship from EDSA g…
MIRM	Mirum Pharmaceuticals, Inc.	72%	Reciprocal relationship from MIRM graph: future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced dem…
CHEMOMAB-THERAPEUTICS-INC	CHEMOMAB-THERAPEUTICS-INC	62%	nd for the years ended December 31, 2025, 2024 and 2023, respectively. See Note 12. The accompanying notes are an integral part of the consolidated financial statements. F - 6 Chemomab Therapeutics L…

Chemomab Therapeutics Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
CMMB-DEBT-8719	Warrants outstanding: 17.35	90%	xbrl warrant detail from xbrl 2021-03-15.

Chemomab Therapeutics Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Chemomab Therapeutics Ltd..

Chemomab Therapeutics Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Chemomab Therapeutics Ltd..

Chemomab Therapeutics Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
EDSA	Edesa Biotech, Inc.	100.00	1	['customer', 'supplier']
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
MRK	Merck & Co., Inc.	100.00	2
SNYNF	Sanofi	100.00	2
TVTX	Travere Therapeutics, Inc.	100.00	2
PRQR	ProQR Therapeutics N.V.	100.00	2
LLY	Eli Lilly and Company	100.00	2
VYNE	VYNE Therapeutics Inc.	100.00	2
ACRS	Aclaris Therapeutics, Inc.	100.00	2
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2
MESO	Mesoblast Limited	100.00	2
MIRM	Mirum Pharmaceuticals, Inc.	100.00	1	['customer', 'supplier']
ORANY	ORANGE	50.00	2
NVS	Novartis AG	50.00	2
SHIRE	SHIRE	50.00	2
MANU	Manchester	50.00	2
CMOS	CMOS	50.00	2
CM	Canadian Imperial Bank of Commerce	14.78	2

Chemomab Therapeutics Ltd. Supply Chain